Yaşa Bağlı Maküla Dejenerasyonu Hastalarında Fotodinamik Tedavi Sonuçları

December 2010
Retina-Vitreus/Journal of Retina-Vitreous;Dec2010, Vol. 18 Issue 4, p289
Academic Journal
No abstract available.


Related Articles

  • Fundus Autofluorescence Before and After Photodynamic Therapy for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Framme, Carsten; Bunse, Arnd; Sofroni, Renata; Thalhammer, Thomas; Walter, Andreas; Sachs, Helmut G.; Gabel, Veit-Peter // Ophthalmic Surgery, Lasers & Imaging;Sep/Oct2006, Vol. 37 Issue 5, p406 

    BACKGROUND AND OBJECTIVE: To describe fundus autofluorescence patterns in choroidal neovascularization secondary to age-related macular degeneration before and after photodynamic therapy (PDT). PATIENTS AND METHODS: Sixty-eight consecutive eyes were indicated for PDT after standard fluorescein...

  • Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration. Misa Suzuki; Norihiro Nagai; Kanako Izumi-Nagai; Hajime Shinoda; Takashi Koto; Atsuro Uchida; Hiroshi Mochimaru; Kenya Yuki; Mariko Sasaki; Kazuo Tsubota; Yoko Ozawa // British Journal of Ophthalmology;Sep2014, Vol. 98 Issue 9, p1186 

    Background/aims To study the initial characteristics and response to intravitreal ranibizumab (IVR) treatment of age-related macular degeneration (AMD). Methods We reviewed the clinical records of 141 eyes in 141 AMD patients who received monthly IVR for 3 months and thereafter pro re nata (PRN)...

  • Proton beam irradiation for non-AMD CNV: 2-year results of a randomised clinical trial. Ling Chen; Kim, Ivana K.; Lane, Anne M.; Gauthier, Danny; Munzenrider, John E.; Gragoudas, Evangelos S.; Miller, Joan W. // British Journal of Ophthalmology;Sep2014, Vol. 98 Issue 9, p1212 

    Aims To evaluate safety and visual outcomes after proton beam irradiation (PBI) therapy for subfoveal choroidal neovascularisation (CNV) secondary to causes other than age-related macular degeneration (AMD). Methods This study is a prospective, unmasked and randomised clinical trial using two...

  • Evaluation of the Potential Acuity Meter in Predicting Visual Acuity After Photodynamic Therapy for Choroidal Neovascularization. Smith, Bradley T.; Vander, James F.; Regillo, Carl D.; Ho, Allen C. // Ophthalmic Surgery, Lasers & Imaging;Jan/Feb2006, Vol. 37 Issue 1, p6 

    BACKGROUND AND OBJECTIVE: To evaluate the potential acuity meter in predicting visual acuity after photodynamic therapy of choroidal neovascular membranes caused by age-related macular degeneration. PATIENTS AND METHODS: Retrospective study of 55 eyes in 51 patients with subfoveal predominantly...

  • Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Costagliola, Ciro; Romano, Mario R.; Rinaldi, Michele; dell'Omo, Roberto; Chiosi, Flavia; Menzione, Massimo; Semeraro, Francesco // British Journal of Ophthalmology;Feb2010, Vol. 94 Issue 2, p180 

    Aims To report the efficacy and safety of intravitreal bevacizumab (IVB) alone versus IVB plus low-fluence photodynamic therapy (PDT) in age-related macular degeneration (AMD) patients and to verify the occurrence of a synergistic effect of the combined approach on visual acuity, size and...

  • Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularisation. Fenton, Caroline; Perry, Caroline M. // Drugs & Aging;2006, Vol. 23 Issue 5, p421 

    Photodynamic therapy (PDT) with verteporfin (Visudyne), a photosensitising protoporphyrin derivative, is used in the management of subfoveal choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) or pathological myopia (PM).PDT with verteporfin over 1 and 2 years...

  • Effects of photodynamic therapy on subfoveal blood flow in neovascular age-related macular degeneration patients. Vinh Moreau-Gaudry, V.; Geiser, M.; Romanet, J. P.; Hera, R.; Millet, J. Y.; Chiquet, C. // Eye;Apr2010, Vol. 24 Issue 4, p706 

    AimTo assess the short-term changes in choroidal blood flow (ChBF) after photodynamic therapy (PDT) in patients with neovascular age-related macular degeneration (AMD).MethodsFourteen patients with exudative AMD were included after a complete ophthalmological examination, fluorescein and...

  • Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration. Potter, Michael J.; Szabo, Shelagh M. // British Journal of Ophthalmology;Jun2007, Vol. 91 Issue 6, p753 

    Aim: To determine the incidence of recurrence of choroidal neovascularisation (CNV) 18 months after cessation of photodynamic therapy (PDT) with verteporfin monotherapy in patients with age-related macular degeneration (AMD). Methods: This was a prospective interventional cohort study. The...

  • Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review. Takeda, A. L.; Coiquilt, J.; Clegg, A. J.; Jones, J. // British Journal of Ophthalmology;Sep2007, Vol. 91 Issue 9, p1177 

    Aims: To assess the clinical effectiveness of pegaptanib sodium and ranibizumab for neovascular age-related macular degeneration (AMD). Methods: A systematic review of randomised controlled trials (RCTs) identified through searching 12 electronic databases, bibliographies and consultation with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics